Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis

Journal of Investigative Dermatology

Volumn 108, Issue 1, 1997, Pages 73-77

  Liou, Amelie ^a   Elias, Peter M ^b   Grunfeld, Carl ^b   Feingold, Kenneth R ^b   Wood, Ladonna C ^b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cutaneous permeability barrier; Cytokines; Occlusion; Transforming growth factor

Indexed keywords

AMPHIREGULIN; MESSENGER RNA; NERVE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN PERMEABILITY;

EID: 0031022561     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12285638     Document Type: Article

References (44)

1. Akhurst RJ, Fee F, Balmain A: Localized production of TGF β mRNA in tumor-stimulated mouse epidermis. Nature 331:363-365, 1988
2. Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet 339:211-214, 1991
3. Barnard JA, Graves-Deal R, Pittelkow MR, DuBois R, Cook P, Ramsey GW, Bishop PR, Damstrup L, Coffey RJ: Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem 269:22817-22822, 1994
4. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
5. Coffey RJ, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR: Production and auto-induction of transforming growth factor alpha in human keratinocytes. Nature 238:817-820, 1987
6. Coffey RJ, Graves-Deal R, Dempsey PJ, Whitehead RH, Pittelkow MR: Differential regulation of transforming growth factor alpha autoinduction in a nontransformed and transformed epithelial cell. Cell Growth Differ 3:347-354, 1992
7. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ, Shipley GD: Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res 52:3224-3227, 1992
8. Cook PW, Pittelkow MR, Shipley GD: Growth factor-independent proliferation of normal human keratinocytes: production of autocrine- and paracrine-acting mitogenic factors. J Cell Physiol 146:277-289, 1991
9. Di Marco E, Marchisio PC, Bondaza S, Franzi AT, Cancedda R, DeLuca M: Growth-related synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 266:21718-21722, 1991
10. Di Marco E, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R, DeLuca M: Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 268:22838-22846, 1993b
11. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, Ellingsworth L, Derynck R, Voorhees JJ: Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243:811-814, 1989
12. Feingold KR: The regulation and role of epidermal lipid synthesis. Adv Lipid Res 24:57-82, 1991
13. Feingold KR, Mao-Quiang M, Menon GK, Cho SS, Brown BE, Elias PM: Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest 86:1738-1745, 1990
14. Finzi E, Harkins R, Horn T: TGF alpha is widely expressed in differentiated as well as hyperproliferative skin epithelium. J Invest Dermatol 96:328-332, 1991
15. Fisher GJ, Tavakkol A, Griffiths CEM, Elder JT, Zhang Q-Y, Finkel L, Danielpour D, Glick AB, Higley H, Ellingsworth L, Voorhees JJ: Differential modulation of transforming growth factor-β1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. J Invest Dermatol 98:102-108, 1992
16. Goustin AS, Leof EB, Shipley GD, Moses HL: Growth factors and cancer. Cancer Res 46:1015-1029, 1986
17. Grubauer G, Elias PM, Feingold KR: Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 30:323-333, 1989
18. Grubauer G, Feingold KR, Elias PM: The relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res 28:746-752, 1987
19. Hancock GE, Kaplan G, Cohn ZA: Keratinocyte growth regulation by the products of immune cells. J Exp Med 168:1395-1402, 1988
20. Holleran WM, Feingold KR, Mao-Quiang M, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 32:1151-1158, 1991a
21. Krieg P, Schnapke R, Furstenberger G, Vogt I, Marks F: TGF-β1 and skin carcino-genesis: antiproliferative effect in vitro and TGF-β1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesis. Mol Carcinog 4:129-137, 1991
22. Levi-Montalcini R: The nerve growth factor 35 years later. Science 237:1154- 1162, 1987
23. Mansbridge JN, Knapp AM, Hanawalt PC, Kane CJM: Rapid appearance of TGFβ after injury to human skin. J Invest Dermatol 92:475, 1989
24. Manthey CL, Allen JB, Ellingsworth LR, Wahl SM: In situ expression of transforming growth factor beta in streptococcal cell wall-induced granulomatous inflammation and hepatic fibrosis. Growth Factors 4:17-26, 1990
25. Menon GK, Feingold KR, Elias PM: The lamellar body secretory response to barrier disruption. J Invest Dermatol 98:279-289, 1992
26. Menon GK, Feingold KR, Moser AH, Brown BE, Elias PM: De novo sterologenesis in the skin, II. Regulation by cutaneous barrier requirements. J Lipid Res 26:418-427, 1985
27. Nickoloff BJ, Naidu Y: Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-546, 1994
28. Nonogaki K, Moser AH, Shigenaga J, Feingold KR, Grunfeld C: β-Nerve growth factor as a mediator of the acute phase response in vivo. Biochem Biophys Res Commun 219:956-961, 1996
29. Otten U, Ehrhard P, Peck R: Nerve growth factor induces growth and differentiation of human beta lymphocytes. Proc Natl Acad Sci USA 86:10059-10063, 1989
30. Pearce FL, Thompson HL: Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 372:379-393, 1986
31. Piepkorn M, Lo C, Plowman G: Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J Cell Physiol (Lond) 159:114-120, 1994
32. Pillai S, Bikle DD, Eessalu TE, Aggarwal BB, Elias PM: Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytes. J Clin Invest 83:816-821, 1989
33. Pincelli C, Sevignani C, Manfredini R, Grande A, Fantini F, Bracci-Laudiero L, L: Aloe, Ferrari S, Cossarizza A, Giannetti A: Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 103:13-18, 1994
34. Proksch E, Feingold KR, Mao-Quiang M, Elias PM: Barrier function regulates epidermal DNA synthesis. J Clin Invest 87:1668-1673, 1991
35. Qian SW, Kondaiah P, Casscells W, Roberts AH, Sporn MB: A second messenger RNA species of transforming growth factor β1 in infarcted rat heart. Cell Regul 2:241-249, 1991
36. Roberts AB, Sporn MB: The transforming growth factor-βs. In: Sporn MB, Roberts AB (eds.) Peptide Growth Factors and Their Receptors, Vol 95-I. Handbook of Experimental Pharmacology. Springer-Verlag, New York, 1990, pp 419-472
37. Sporn MB, Roberts AB: Transforming growth factor-β: recent progress and new challenges. J Cell Biol 119:1017-1021, 1992
38. Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB: Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J Cell Biol 108:661-669, 1989
39. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder N: Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 85:1085-1089, 1990
40. Tsai JC, Feingold KR, Crumrine D, Wood LC, Grunfeld C, Elias PM: Permeability barrier disruption alters the localization and expression of TNFα protein in the epidermis. Arch Dermatol Res 286:242-248, 1994
41. Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR: Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106:397-403, 1996
42. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld C, Feingold KR: Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 103:834-838, 1994b
43. Wood LC, Feingold KR, Sequeira-Martin SM, Elias PM, Grunfeld C: Barrier function coordinately regulates epidermal IL 1 and IL 1ra mRNA levels. Exp Dermatol 3:56-60, 1994a
44. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487, 1992